Septic Bursitis, a Potential Complication of Protease Inhibitor Use in Hepatitis C Virus

Author： Burke Caitlin C.   Martel-Laferriere Valerie   Dieterich Douglas T.  

Publisher： Oxford University Press

ISSN： 1058-4838

Source： Clinical Infectious Diseases, Vol.56, Iss.10, 2013-05, pp. : 1507-1508

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hepatitis C Virus NS3/4A Protease Inhibitors

By  

Recent Patents on Anti-Infective Drug Discovery, Vol. 3, Iss. 3, 2008-11 ,pp. : 157-167

Bentham Science Publishers

Access to resources Recommend Favorite

Polypharmacy and Comorbidity Are Associated with a Lower Early Virologic Response in Hepatitis C Patients Treated with First Generation Protease Inhibitor Triple Therapy: A Preliminary Analysis

By Juneja Manie   Euliano Rebekah   Satoskar Rohit   Lewis James  

Digestive Diseases and Sciences, Vol. 58, Iss. 11, 2013-11 ,pp. : 3348-3358

Springer Publishing Company

Access to resources Recommend Favorite

Perspectives for a hepatitis C virus vaccine

By Abrignani S.   Rosa D.  

Clinical and Diagnostic Virology, Vol. 10, Iss. 2, 1998-07 ,pp. : 181-185

Elsevier

Access to resources Recommend Favorite

Molecular biology of hepatitis C virus

By Suzuki Tetsuro   Aizaki Hideki   Murakami Kyoko   Shoji Ikuo   Wakita Takaji  

Journal of Gastroenterology, Vol. 42, Iss. 6, 2007-06 ,pp. : 411-423

Springer Publishing Company

Access to resources Recommend Favorite

Hepatitis C Virus and Dendritic Cells

By  

Current Immunology Reviews, Vol. 2, Iss. 4, 2006-01 ,pp. : 305-312

Bentham Science Publishers

Access to resources Recommend Favorite